These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2868535)

  • 41. [Has the time come to measure the hemodynamic response to pharmaco-logical treatments of portal hypertension?].
    Morales J; Péron JM; Vinel JP
    Gastroenterol Clin Biol; 2001 Oct; 25(10):863-5. PubMed ID: 11852386
    [No Abstract]   [Full Text] [Related]  

  • 42. An advance in the treatment of portal hypertension?
    Wong F; Blendis L
    Gastroenterology; 2000 Apr; 118(4):802-3. PubMed ID: 10734033
    [No Abstract]   [Full Text] [Related]  

  • 43. Beta-blockers in portal hypertension: variation on a theme.
    Brady CE
    Am J Gastroenterol; 1992 Jul; 87(7):921-2. PubMed ID: 1615953
    [No Abstract]   [Full Text] [Related]  

  • 44. Portal hypertension. Update on pathophysiology and management.
    Chatila R
    J Med Liban; 2001; 49(2):101-5. PubMed ID: 11910964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of variceal bleeding and measurement of hepatic vein pressure gradient].
    Youn KH; Kim DJ
    Korean J Hepatol; 2006 Sep; 12(3):464-8. PubMed ID: 16998301
    [No Abstract]   [Full Text] [Related]  

  • 46. [Medical treatment of portal hypertension].
    Lebrec D
    Presse Med; 1991 Apr; 20(16):750-5. PubMed ID: 1675466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The pharmacologic treatment of portal hypertension].
    Guevara L
    Rev Gastroenterol Mex; 1984; 49(4):207-9. PubMed ID: 6152355
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug therapy and prevention of hemorrhage in esophageal and gastric varices].
    Kitsenko EA; Peresta IuIu
    Klin Med (Mosk); 1995; 73(2):12-6. PubMed ID: 7541875
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of esmolol in patient with portal hypertension].
    Figueroa Yusta J; Gilsanz F; De Dios Tomás E
    Rev Esp Anestesiol Reanim; 2001; 48(7):349. PubMed ID: 11591288
    [No Abstract]   [Full Text] [Related]  

  • 52. Beta-blockers to prevent gastroesophageal varices in cirrhosis.
    Assy NN; Schlesinger SE; Hussein OA
    N Engl J Med; 2006 Mar; 354(12):1318-20; author reply 1318-20. PubMed ID: 16557665
    [No Abstract]   [Full Text] [Related]  

  • 53. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic management of portal hypertension.
    Berzigotti A; Bosch J
    Clin Liver Dis; 2014 May; 18(2):303-17. PubMed ID: 24679496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol.
    Senzolo M; Cholongitas E; Marelli L; Thalheimer U; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Oct; 101(10):2436-7. PubMed ID: 17032210
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
    Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H
    Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A short cut to predict the clinical response to beta-blocker therapy in cirrhosis?
    Merkel C
    J Hepatol; 2009 Aug; 51(2):268-70. PubMed ID: 19515449
    [No Abstract]   [Full Text] [Related]  

  • 58. Endoscopic demonstration that vasopressin but not propranolol produces gastric mucosal ischemia in dogs with portal hypertension.
    Leung FW; Jensen DM; Guth PH
    Gastrointest Endosc; 1988; 34(4):310-3. PubMed ID: 3261702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Propranolol in the treatment of portal hypertension: a caution.
    Conn HO
    Hepatology; 1982; 2(5):641-4. PubMed ID: 6981577
    [No Abstract]   [Full Text] [Related]  

  • 60. Portal hypertension and its management in children.
    Grammatikopoulos T; McKiernan PJ; Dhawan A
    Arch Dis Child; 2018 Feb; 103(2):186-191. PubMed ID: 28814423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.